Ibuprofen
NDC 83209-464, Ibuprofen, tablet, from Boswell Pharmacy Services LLC d/b/a BPS Wholesale.
- Product NDC
- 83209-464
- Status
- Listed
- Labeler
- Boswell Pharmacy Services LLC d/b/a BPS Wholesale
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA078558
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/83209-464 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- IBUPROFEN400 mg/1
Pharmacologic classes
Anti-Inflammatory Agents, Non-Steroidal [CS]; Cyclooxygenase Inhibitors [MoA]; Nonsteroidal Anti-inflammatory Drug [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 83209-464-09 | 83209046409 | 9 TABLET in 1 BLISTER PACK (83209-464-09) |
| 83209-464-10 | 83209046410 | 10 TABLET in 1 BLISTER PACK (83209-464-10) |
| 83209-464-12 | 83209046412 | 12 TABLET in 1 BLISTER PACK (83209-464-12) |
| 83209-464-14 | 83209046414 | 14 TABLET in 1 BLISTER PACK (83209-464-14) |
| 83209-464-15 | 83209046415 | 15 TABLET in 1 BLISTER PACK (83209-464-15) |
| 83209-464-18 | 83209046418 | 18 TABLET in 1 BLISTER PACK (83209-464-18) |
| 83209-464-20 | 83209046420 | 20 TABLET in 1 BLISTER PACK (83209-464-20) |
| 83209-464-21 | 83209046421 | 21 TABLET in 1 BLISTER PACK (83209-464-21) |
| 83209-464-24 | 83209046424 | 24 TABLET in 1 BLISTER PACK (83209-464-24) |
| 83209-464-28 | 83209046428 | 28 TABLET in 1 BLISTER PACK (83209-464-28) |
| 83209-464-30 | 83209046430 | 30 TABLET in 1 BLISTER PACK (83209-464-30) |
| 83209-464-40 | 83209046440 | 40 TABLET in 1 BLISTER PACK (83209-464-40) |
| 83209-464-60 | 83209046460 | 60 TABLET in 1 BLISTER PACK (83209-464-60) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/1a02fa34-b5ae-7183-e063-6294a90a3ae4
Use it
Look up 83209-464 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/83209-464 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 83209-464. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.